Infliximab home infusion draft standard operating procedure

Abstract

The research indicates that infliximab home infusion treatment is complex and requires careful consideration of various aspects of patient care and coordination of services. The literature clarifies that standardization is needed to foster quality and safety in infliximab infusion home based care. Patient care and clinical outcomes will continue to be jeopardized in the absence of a standard operating procedure (SOP) for home infusion nurses (RNs) to access, consult with, and inform infliximab home infusion care. Within Alberta, Canada, home-based infliximab infusions have become a service offered to patients and families. However, there is no evidence suggesting that an SOP related to infliximab infusion home-based care exists, specifically within the Canadian INVIVA McKesson organization. I developed an evidence-based draft SOP for infliximab home infusion treatment tailored to the INVIVA McKesson Canada organization through this project. I engaged with stakeholders from varying professional backgrounds to validate and improve the draft SOP.